News | April 03, 2008

St. Jude's CRT-D, ICD Extend their Lead with Durata

April 4, 2008 - St. Jude Medical placed at center stage at ACC the company’s Promote RF CRT-D and Current ICD, combined with the new Durata lead, and the QuickOpt Timing Cycle Optimization.

The Promote RF CRT-D and Current RF ICD, which feature InvisiLink radiofrequency (RF) telemetry for reportedly secure, wireless communication between the implanted device and the programmer, have extended their reach with the new Durata lead.

The Durata defibrillation lead is the first St. Jude Medical lead with an innovative soft lead tip and slightly curved RV coil, designed to optimize the lead tip-endocardium interface.

Representing the latest advancements in lead technology, the Durata lead features exclusive technologies designed for long-term reliability, more control during implantation, and options to accommodate varying patient needs and physician preferences - all while being the thinnest of any competitive lead on the market.

QuickOpt Timing Cycle Optimization was another tool on display, offering alternative to time-consuming echocardiography procedures. By programming appropriate AV and VV delays (timing cycle optimization), research has shown to be effective at improving patient outcomes by increasing cardiac output and reducing non-responder rates.

Related Content

Biotronik Launches DX Technology for U.S. Heart Failure Patients
News | Cardiac Resynchronization Therapy Devices (CRT)| July 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and availability of the Intica DX and Intica...
Predictive Models May Help Determine Which Patients Benefit From ICDs
News | Implantable Cardioverter Defibrillator (ICD)| July 06, 2017
Two predictive models may help cardiologists decide which patients would most benefit from an implantable cardioverter...
Medtronic Reactive ATP Therapy Slows Progression of Atrial Fibrillation in Real-World Population
News | Atrial Fibrillation| July 03, 2017
Medtronic recently announced that its Reactive ATP therapy slows the progression of atrial fibrillation (AF) in...
Sponsored Content | Videos | Cardiovascular Ultrasound| June 29, 2017
Leyla Elif Sade, M.D., MESC, professor of cardiology at Başkent University, Ankara, Turkey, discusses use of echo for
Biosense webster multielectrode balloon RF ablation catheter

The Biosense Webster multi-electrode balloon RF ablation catheter. Each electrode can have varied power settings to avoid damage to underlying tissues like the esophagus. 

Feature | EP Lab| June 22, 2017 | Dave Fornell
Electrophysiology (EP) technology has been advancing rapidly the past few years with new ablation tools to improve...
Pacemakers and Other Cardiac Devices Can Help Solve Forensic Cases
News | Pacemakers| June 20, 2017
Pacemakers and other cardiac devices can help solve forensic cases, according to a study presented at the European...
Sponsored Content | Videos | Implantable Cardioverter Defibrillator (ICD)| June 01, 2017
Lucas Boersma, M.D., Ph.D., FESC, St.
Sponsored Content | Videos | Leads Implantable Devices| May 25, 2017
Bruce Wilkoff, M.D., director of cardiac pacing and tachyarrhythmia devices at Cleveland Clinic, discusses advancemen
Overlay Init